Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Standard versus intensified chemotherapy with pegfilgrastim in limited-stage small cell lung cancer
2006-005754-80Phase 3Terminated
- Sponsor
- Karolinska University Hospital
- Start
- Aug 2007
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised trial of pegfilgrastim in small cell lung cancer (SCLC) (2 arms), sponsored by Karolinska University Hospital. Primary endpoint: 2-year survival. Started Aug 2007; status: terminated.
02
Drugs
pegfilgrastim
03
Conditions
small cell lung cancer (SCLC)
Beyond the preview
Go deeper on 2006-005754-80.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-005754-80.